Pharmafile Logo
Pharmafocus logo
Advanced Search
sensimed_lens

Wireless contact lens sensor approved by FDA

March 8, 2016
Manufacturing and Production, Research and Development, Sales and Marketing

The US Food and Drug Administration has allowed the marketing of a contact lens sensor that may help practitioners identify …

News
abbvie

AbbVie pays $595m upfront for experimental Boehringer psoriasis drug

March 8, 2016
Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, BI 655066, Boehringer Ingelheim, psoriasis

AbbVie is betting big on the future of an experimental psoriasis drug, paying $595m upfront for the rights to Boehringer …

News
rd_hands

Shares in Celldex halve in value as it discontinues trial of brain cancer drug

March 8, 2016
Manufacturing and Production, Research and Development Cancer, Celldex, research

Shares in Celldex Therapeutics (Nasdaq: CLDX) more than halved in value on the Nasdaq Monday as the company said independent regulators …

News
7-0_careers_taleobanner_900x600

Onconova says Baxalta ends $565 million drug development deal for rigosertib

March 8, 2016
Manufacturing and Production, Research and Development Baxalta, Onconova Therapeutics, drug development, rigosertib

Onconova Therapeutics says Baxalta has terminated its $565 million agreement to jointly develop the company’s lead drug candidate rigosertib. Baxalta …

News
msd

Merck says US FDA accepts its sBLA for Keytruda

March 8, 2016
Manufacturing and Production, Research and Development Merck & Co, US FDA, keytruda, melanoma

US pharma giant Merck & Co said the US Food and Drug Administration (FDA) has accepted for review a new …

News
gsk_corp_hq_brentford_2

GSK says long-term study for Nucala backs safety profile

March 8, 2016
Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, Nucala, asthma

UK pharma major GlaxoSmithKline (LSE: GSK) said its asthma drug, Nucala (mepolizumab) showed a similar safety profile in a long-term …

News
ema_logo

EMA launches PRIME scheme

March 8, 2016
Manufacturing and Production, Research and Development EMA, Guido Rasi, PRIME

The European Medicines Agency (EMA) has launched its new PRIME (priority medicines) scheme, which aims to strengthen support to medicines …

News
astrazeneca_plaque

AstraZeneca’s Faslodex gets US FDA nod in combination treatment for breast cancer

March 8, 2016
Manufacturing and Production, Research and Development AstraZeneca, Faslodex, US FDA, palbociclib

UK drug-maker AstraZeneca said the US Food and Drug Administration (FDA) has approved a new indication expanding the use of …

News
bms

BMS criticises Scottish regulator over Opdivo skin cancer ‘no’

March 7, 2016
Medical Communications, Research and Development Bristol-Myers Sqibb, NICE, SMC, melanoma, opdivo

Bristol-Myers Squibb says the Scottish Medicines Consortium’s (SMC) decision not to recommend its immunotherapy Opdivo (nivolumab) as a monotherapy for …

News
abbvie_0

AbbVie’s Imbruvica gets US FDA okay as first-line treatment for CLL

March 7, 2016
Sales and Marketing AbbVie, Janssen, Janssen Biotech, US FDA, imbruvica

Drug maker AbbVie said the US Food and Drug Administration (FDA) has approved its Imbruvica (ibrutinib) as a first-line treatment …

News
eli_lilly

Eli Lilly’s plaque psoriasis treatment impresses in Phase III trials

March 7, 2016
Research and Development, Sales and Marketing Eli Lilly, Enbrel, ixekizumab, psoriasis

Eli Lilly has announced late-stage trial data showing ixekuzimab treatment resulted in clinically meaningful improvements in as early as one …

News
rd_hands

Japan’s Ono Pharma focusing on building immuno-oncology portfolio with Opdivo

March 7, 2016
Sales and Marketing Bristol-Myers Sqibb, Ono Pharma, immuno-oncology, opdivo

Japan’s Ono Pharmaceutical has said it is focused on building on its immuno-oncology portfolio following the success of its PD-1 …

News
novo_nordisk

Novo Nordisk reports five-year Victoza cardiovascular safety data

March 7, 2016
Research and Development, Sales and Marketing Novo Nordisk, Victoza

Novo Nordisk has announced the top-line results from a trial investigating the cardiovascular safety of Victoza (liraglutide [rDNA origin] injection) …

News
csl_behring

FDA approves CSL Behring’s new haemophilia B treatment

March 7, 2016
Research and Development, Sales and Marketing CSL Behring, haemophilia

The US Food and Drug Administration (FDA) has approved CSL Behring’s Idelvion (Coagulation Factor IX (Recombinant)), a novel, long-acting albumin …

News

Novartis says its psoriasis drug bests Janssen’s in comparison study

March 7, 2016
Research and Development, Sales and Marketing Cosentyx, Novartis, Stelara

Novartis has announced new data from a study comparing its drug Cosentyx to Janssen’s Stelara, which it says demonstrates Cosentyx’s …

News
teva_copy

Teva suffers EpiPen generic setback after FDA rejection

March 4, 2016
Medical Communications, Research and Development FDA, Teva, analphylaxis, approval, auto injector, auto-injector, rejection

The release of Teva Pharmaceuticals generic for the anaphylaxis treatment, EpiPen (epinephrine), is now expected to be severely delayed after …

News
rd_hands

BioMarin reports positive early-stage results for trial drug to treat CLN2 disease

March 4, 2016
Medical Communications

Biotechnology firm BioMarin Pharmaceutical has announced positive results from early stage trial for drug to treat neurodegenerative disease in children.  …

News
merck_logo_blue_rgb

Merck & Pfizer tie-up with Verastem to develop ovarian cancer drug

March 4, 2016
Medical Communications

German drug major Merck along with Pfizer has joined forces with Verastem to develop the trial drug candidate avelumab to …

News
sanofi_logo_vertical_2011_4colors

Sanofi Genzyme present positive Phase 2 results for fatal neuromuscular disease treatment

March 4, 2016
Medical Communications, Research and Development Pompe disease, Sanofi, clinical trial, neuromuscular, phase 2

Sanofi Genzyme, the branch of the French-based pharma company that focuses on diseases difficult to diagnose and treat, have published …

News
magic_bullets_pills

Almost half of US physicians will prescribe more biosimilars, according to survey

March 4, 2016
Medical Communications Obama, US, biosimilar, patent, prescribing

New data published by InCrowd has suggested that US physicians are very amenable to the prescription of biosimilars, with some …

News
The Gateway to Local Adoption Series

Latest content

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026